Taysha Gene Therapies, Inc. (TSHA)

CIK 1806310 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Taysha Gene Therapies, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000928
Aug 13, 2026SCHEDULE 13G/A0000895421-26-000269
Aug 11, 202610-Q0001193125-26-344610
Aug 11, 20268-K0001193125-26-344594
Jul 10, 202640001665124-26-000013
Jul 10, 20261440001974158-26-000076
Jun 25, 2026424B50001193125-26-282846
Jun 25, 20268-K0001193125-26-282855
Jun 24, 2026424B50001193125-26-281288
Jun 22, 20268-K0001193125-26-276738
Jun 2, 202640001777421-26-000005
Jun 2, 202640001891712-26-000002
Jun 2, 20268-K0001193125-26-253478
Jun 2, 202640001709418-26-000002
Jun 2, 202640001238120-26-000008
May 15, 2026SCHEDULE 13G/A0001493215-26-000122
May 15, 2026SCHEDULE 13G/A0000902664-26-002553
May 6, 20268-K0001193125-26-207633
May 6, 202610-Q0001193125-26-207666
Apr 22, 2026DEFA14A0001193125-26-168533
Apr 22, 2026ARS0001193125-26-168538
Apr 22, 2026DEF 14A0001193125-26-168525
Apr 13, 202640001665124-26-000011
Apr 10, 20261440001974158-26-000040
Mar 19, 20268-K0001193125-26-115177